- Tytuł :
- When Therapeutic IgA Antibodies Might Come of Age
- Autorzy :
- Temat :
-
Immunoglobulin A
Therapeutic antibody
Bioengineering
Primary antibody deficiency
MESH: Animals
MESH: Anti-Inflammatory Agents / therapeutic use
MESH: Host-Pathogen Interactions
MESH: Humans
MESH: Immunoglobulin A / adverse effects
MESH: Immunoglobulin A / therapeutic use
MESH: Immunotherapy* / adverse effects
MESH: Inflammation / drug therapy
MESH: Inflammation / immunology
MESH: Mice
MESH: Neoplasms / drug therapy
MESH: Neoplasms / immunology
MESH: Antibodies, Monoclonal / adverse effects
MESH: SARS-CoV-2 / immunology
MESH: Antibodies, Monoclonal / therapeutic use
MESH: Antineoplastic Agents, Immunological / therapeutic use
MESH: Antiviral Agents / adverse effects
MESH: Antiviral Agents / therapeutic use
MESH:COVID-19 / drug therapy
MESH:COVID-19 / immunology
MESH:COVID-19 /virology
[SDV.IMM]Life Sciences [q-bio]/Immunology - Źródło :
-
Pharmacology
Pharmacology, Karger, 2021, 106 (1-2), pp.9-19. ⟨10.1159/000510251⟩ - Dostępność :
-
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6eb83c7f325b6b1b0a3eaa9a88cac25b
https://hal.sorbonne-universite.fr/hal-03139698